Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Hunsicker

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|November 11, 1993
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study GroupE J Lewis, L G Hunsicker, R P Bain, et al.
Transplantation Proceedings|February 1, 1993
Effect of center size and patient-mix covariates on transplant center-specific patient and graft survival in the United StatesL G Hunsicker, E B Edwards, T J Breen, et al.
Kidney International. Supplement|February 1, 1994
Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study GroupJ A Breyer, L G Hunsicker, R P Bain, et al.
Archives of Pathology & Laboratory Medicine|December 11, 1976
Acute renal failure following halothane anesthesiaJ R Cotton, M M Schwartz, J D Lindley, et al.
Pharmacotherapy|April 17, 1998
Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantationD I Min, P J Perry, H Y Chen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2008
OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation?B M Sulieman, L G Hunsicker, D A Katz, et al.
Kidney International|April 14, 2006
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspectiveH-H Parving, J B Lewis, M Ravid, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1992
A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study GroupR Bain, R Rohde, L G Hunsicker, et al.
Journal of the Iowa Medical Society|February 1, 1981
Improving survival rates in renal transplantationR J Corry, N E Goeken, D D Nghiem, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1980
Transfusion and renal allograft survival: beneficial effect of transfusions given on day of transplantationL G Hunsicker, L S Oei, R M Freeman, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|November 11, 1993
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study GroupE J Lewis, L G Hunsicker, R P Bain, et al.
Transplantation Proceedings|February 1, 1993
Effect of center size and patient-mix covariates on transplant center-specific patient and graft survival in the United StatesL G Hunsicker, E B Edwards, T J Breen, et al.
Kidney International. Supplement|February 1, 1994
Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study GroupJ A Breyer, L G Hunsicker, R P Bain, et al.
Archives of Pathology & Laboratory Medicine|December 11, 1976
Acute renal failure following halothane anesthesiaJ R Cotton, M M Schwartz, J D Lindley, et al.
Pharmacotherapy|April 17, 1998
Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantationD I Min, P J Perry, H Y Chen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2008
OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation?B M Sulieman, L G Hunsicker, D A Katz, et al.
Kidney International|April 14, 2006
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspectiveH-H Parving, J B Lewis, M Ravid, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1992
A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study GroupR Bain, R Rohde, L G Hunsicker, et al.
Journal of the Iowa Medical Society|February 1, 1981
Improving survival rates in renal transplantationR J Corry, N E Goeken, D D Nghiem, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1980
Transfusion and renal allograft survival: beneficial effect of transfusions given on day of transplantationL G Hunsicker, L S Oei, R M Freeman, et al.
Pageof 8